Cognitive shadows in perimenopause: linking subjective cognitive decline (SCD) to menopausal symptom severity

References

• Reuben R, Karkaby L, McNamee C, et al. Menopause and cognitive complaints: are ovarian hormones linked with subjective cognitive decline? Climacteric. 2021;24(4):321–332. doi: 10.1080/13697137.2021.1892627.
   PubMed Web of Science ®Google Scholar
• Mitchell ES, Woods NF. Cognitive symptoms during the menopausal transition and early postmenopause. Climacteric. 2011;14(2):252–261. doi: 10.3109/13697137.2010.516848.
   PubMed Web of Science ®Google Scholar
• Sullivan Mitchell E, Fugate Woods N. Midlife women’s attributions about perceived memory changes: observations from the Seattle midlife women’s health study. J Womens Health Gend Based Med. 2001;10(4):351–362. doi: 10.1089/152460901750269670.
   PubMedGoogle Scholar
• Piauilino DC, Bueno OFA, Tufik S, et al. The prospective and retrospective memory questionnaire: a population-based random sampling study. Memory. 2010;18(4):413–426. doi: 10.1080/09658211003742672.
   PubMed Web of Science ®Google Scholar
• Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet. 2020;396(10248):413–446. doi: 10.1016/S0140-6736(20)30367-6.
   PubMed Web of Science ®Google Scholar
• Scheyer O, Rahman A, Hristov H, et al. Female sex and alzheimer’s risk: the menopause connection. J Prev Alz Dis. 2018;5(4):225–230. doi: 10.14283/jpad.2018.34.
   Web of Science ®Google Scholar
• Jessen F, Amariglio RE, Buckley RF, et al. The characterisation of subjective cognitive decline. Lancet Neurol. 2020;19(3):271–278. doi: 10.1016/S1474-4422(19)30368-0.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ, Beaumont H, Ferguson D, et al. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis. Acta Psychiatr Scand. 2014;130(6):439–451. doi: 10.1111/acps.12336.
   PubMed Web of Science ®Google Scholar
• Uddin M, Rahman M, Jakaria M, et al. Estrogen signaling in alzheimer’s disease: molecular insights and therapeutic targets for alzheimer’s dementia. Mol Neurobiol. 2020;57(6):2654–2670. doi: 10.1007/s12035-020-01911-8.
   PubMed Web of Science ®Google Scholar
• Koyama AK, Tworoger SS, Eliassen AH, et al. Endogenous sex hormones and cognitive function in older women. Alzheimers Dement. 2016;12(7):758–765. doi: 10.1016/j.jalz.2015.12.010.
   PubMed Web of Science ®Google Scholar
• Drogos LL, Rubin LH, Geller SE, et al. Objective cognitive performance is related to subjective memory complaints in midlife women with moderate to severe vasomotor symptoms. Menopause. 2013;20(12):1236–1242. doi: 10.1097/GME.0b013e318291f5a6.
   PubMed Web of Science ®Google Scholar
• Maki PM, Thurston RC. Menopause and brain health: hormonal changes are only part of the story. Front Neurol. 2020;11:562275. doi: 10.3389/fneur.2020.562275.
   PubMed Web of Science ®Google Scholar
• Jessen F, Amariglio RE, Boxtel M, et al. A conceptual framework for research on subjective cognitive decline in preclinical alzheimer’s disease. Alzheimers Dement. 2014;10(6):844–852. doi: 10.1016/j.jalz.2014.01.001.
   PubMed Web of Science ®Google Scholar
• Gifford KA, Liu D, Romano RR, et al. Development of a subjective cognitive decline questionnaire using item response theory: a pilot study. Alzheimers Dement (Amst). 2015;1(4):429–439. doi: 10.1016/j.dadm.2015.09.004.
   PubMedGoogle Scholar
• Hao L, Jia J, Xing Y, et al. An application study-subjective cognitive ­decline Questionnaire9 in detecting mild cognitive impairment (MCI). Aging Ment Health. 2022;26(10):2014–2021. doi: 10.1080/13607863.2021.1980860.
   PubMed Web of Science ®Google Scholar
• Tao M, Shao H, Li C, et al. Correlation between the modified kupperman index and the menopause rating scale in Chinese women. Patient Prefer Adherence. 2013;7:223–229. doi: 10.2147/PPA.S42852.
   PubMed Web of Science ®Google Scholar
• Harlow SD, Gass M, Hall JE, et al. Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97(4):1159–1168. doi: 10.1210/jc.2011-3362.
   PubMed Web of Science ®Google Scholar
• Kupperman HS, Blatt MHG, Wiesbader H, et al. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices*†. J Clin Endocrinol Metab. 1953;13(6):688–703. doi: 10.1210/jcem-13-6-688.
   PubMed Web of Science ®Google Scholar
• Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol. 2000;152(5):463–473. doi: 10.1093/aje/152.5.463.
   PubMed Web of Science ®Google Scholar
• Monteleone P, Mascagni G, Giannini A, et al. Symptoms of menopause - global prevalence, physiology and implications. Nat Rev Endocrinol. 2018;14(4):199–215. doi: 10.1038/nrendo.2017.180.
   PubMed Web of Science ®Google Scholar
• Lee SJ, McEwen BS. Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu Rev Pharmacol Toxicol. 2001;41(1):569–591. doi: 10.1146/annurev.pharmtox.41.1.569.
   PubMedGoogle Scholar
• Pike CJ. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer’s disease. J Neurochem. 1999;72(4):1552–1563. doi: 10.1046/j.1471-4159.1999.721552.x.
   PubMed Web of Science ®Google Scholar
• Lord C, Buss C, Lupien SJ, et al. Hippocampal volumes are larger in postmenopausal women using estrogen therapy compared to past users, never users and men: a possible window of opportunity effect. Neurobiol Aging. 2008;29(1):95–101. doi: 10.1016/j.neurobiolaging.2006.09.001.
   PubMed Web of Science ®Google Scholar
• Xiong J, Kang SS, Wang Z, et al. FSH blockade improves cognition in mice with alzheimer’s disease. Nature. 2022;603(7901):470–476. doi: 10.1038/s41586-022-04463-0.
   PubMed Web of Science ®Google Scholar
• Matyi JM, Rattinger GB, Schwartz S, et al. Lifetime estrogen exposure and cognition in late life: the cache county study. Menopause. 2019;26(12):1366–1374. doi: 10.1097/GME.0000000000001405.
   PubMed Web of Science ®Google Scholar
• Zandi PP, Carlson MC, Plassman BL, et al. Hormone replacement therapy and incidence of Alzheimer disease in older women: the cache county study. JAMA. 2002;288(17):2123–2129. doi: 10.1001/jama.288.17.2123.
   PubMed Web of Science ®Google Scholar
• O'Brien J, Jackson JW, Grodstein F, et al. Postmenopausal hormone therapy is not associated with risk of all-cause dementia and alzheimer’s disease. Epidemiol Rev. 2014;36(1):83–103. doi: 10.1093/epirev/mxt008.
   PubMed Web of Science ®Google Scholar
• Espeland MA, Rapp SR, Shumaker SA, et al. Conjugated equine ­estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: women’s health initiative memory study. JAMA. 2004;291(24):2959–2968. doi: 10.1001/jama.291.24.2947.
   PubMed Web of Science ®Google Scholar
• Omura JD, McGuire LC, Patel R, et al. Modifiable risk factors for ­alzheimer disease and related dementias among adults aged ≥45 years—United States, 2019. MMWR Morb Mortal Wkly Rep. 2022;71(20):680–685. doi: 10.15585/mmwr.mm7120a2.
   PubMed Web of Science ®Google Scholar